These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 362942)
21. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF). Wright SC; Bonavida B J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909 [TBL] [Abstract][Full Text] [Related]
22. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2. Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989 [TBL] [Abstract][Full Text] [Related]
23. Purification and target cell range of in vivo elicited blast natural killer cells. Biron CA; Pedersen KF; Welsh RM J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814 [TBL] [Abstract][Full Text] [Related]
24. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells. Burns GF; Triglia T; Werkmeister JA J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374 [TBL] [Abstract][Full Text] [Related]
25. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells. Frey JR; Kamber M; Peck R Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569 [TBL] [Abstract][Full Text] [Related]
26. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells. Grönberg A; Hansson M; Kiessling R; Andersson B; Kärre K; Roder J J Natl Cancer Inst; 1980 May; 64(5):1113-9. PubMed ID: 6966004 [TBL] [Abstract][Full Text] [Related]
27. Spontaneous alloreactivity of natural killer (NK) and lymphokine-activated killer (LAK) cells from athymic rats against normal haemic cells. NK cells stimulate syngeneic but inhibit allogeneic haemopoiesis. Rolstad B; Benestad HB Immunology; 1991 Sep; 74(1):86-93. PubMed ID: 1937576 [TBL] [Abstract][Full Text] [Related]
28. Significance of target cell infection and natural killer cells in the anti-tumor effects of bacillus Calmette-Guerin in murine bladder cancer. Sonoda T; Sugimura K; Ikemoto S; Kawashima H; Nakatani T Oncol Rep; 2007 Jun; 17(6):1469-74. PubMed ID: 17487406 [TBL] [Abstract][Full Text] [Related]
29. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells. Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295 [TBL] [Abstract][Full Text] [Related]
30. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals. Suthanthiran M; Williams PS; Solomon SD; Rubin AL; Stenzel KH J Clin Invest; 1984 Dec; 74(6):2263-71. PubMed ID: 6392343 [TBL] [Abstract][Full Text] [Related]
31. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells. Arancia G; Malorni W; Donelli G Ann Ist Super Sanita; 1990; 26(3-4):369-84. PubMed ID: 2151107 [TBL] [Abstract][Full Text] [Related]
32. BCG induced murine peritoneal exudate cells: cytotoxic activity against a syngeneic bladder tumor cell line. Pang AS; Morales A J Urol; 1982 Jun; 127(6):1225-9. PubMed ID: 7087042 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of SK cell activity in frogs by certain drugs and sugars. Ghoneum M; Cooper EL; Smith C Dev Comp Immunol; 1987; 11(2):363-73. PubMed ID: 3497828 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of natural killer cell-mediated cytotoxicity by ML-9, a selective inhibitor of myosin light chain kinase. Ito M; Tanabe F; Sato A; Ishida E; Takami Y; Shigeta S Int J Immunopharmacol; 1989; 11(2):185-90. PubMed ID: 2703279 [TBL] [Abstract][Full Text] [Related]
36. The biology of the human natural killer cell. Roder JC; Pross HF J Clin Immunol; 1982 Oct; 2(4):249-63. PubMed ID: 6292259 [TBL] [Abstract][Full Text] [Related]
37. Tumor cell killing by macrophages activated in vitro with lymphocyte mediators. III. Inhibition by cytochalasins, colchicine, and vinblastine. Sharma SD; Piessens WF Cell Immunol; 1978 Jul; 38(2):276-85. PubMed ID: 209902 [No Abstract] [Full Text] [Related]
38. [No breakthrough in tumor immunology]. Ring J MMW Munch Med Wochenschr; 1978 Sep; 120(35):1102-3. PubMed ID: 308600 [No Abstract] [Full Text] [Related]
39. Corynebacterium parvum stimulation of adherent and non-adherent cytotoxic cells in mice. Hassan ZM; Rees RC; Potter CW Br J Cancer; 1981 Oct; 44(4):532-8. PubMed ID: 7295509 [TBL] [Abstract][Full Text] [Related]
40. NK cell-target interactions: approaches towards definition of recognition structures. Urdal DL; Kawase I; Henney CS Cancer Metastasis Rev; 1982; 1(1):65-81. PubMed ID: 7185420 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]